No Data
No Data
ST Jiaotong (600530.SH): Controlling shareholders and concerted actors increased their holdings by 1.25%
ST Jiaonang (600530.SH) announced that as of May 27, 2024, Shanghai Yunjian, the controlling shareholder of the company...
ST Jiaon (600530.SH): Does not produce medical freeze-dryer equipment
Gelonghui, May 27丨ST Jiaonang (600530.SH) said on the investor interactive platform that the company does not produce medical freeze-dryer equipment. Please pay attention to the company's announcements in the legally disclosed media for the company's relevant information.
ST Jiao Ang (600530.SH) issued an advance loss, and the net loss in 2023 is expected to be about 32 million yuan, a year-on-year reduction of 93%
ST Jiaonang (600530.SH) disclosed the 2023 annual results pre-loss announcement. The company expects to belong during the reporting period...
ST Jiao Ang (600530.SH): Currently, the main business is still health products and medical care
On December 7, Gelonghui (600530.SH) said at the performance briefing that the company's current main business is still health products and medical care. Please continue to pay attention to the company's announcements in the statutory disclosure media for relevant information.
ST Jiao Ang (600530.SH): Up to now, the company has completed the correction of previous accounting errors
On December 7, Gelonghui (600530.SH) said at the performance briefing that up to now, the company has completed the correction of prior accounting errors and completed a comprehensive audit of the 2021 revised financial statements in accordance with relevant regulations. The company will continue to improve the implementation and audit and supervision mechanisms of the internal control system, comprehensively sort out and standardize internal control processes, strengthen internal control inspection in key risk areas, effectively guarantee the effective implementation of the internal control system, continuously improve the company's standardized operation level, and protect the legitimate rights and interests of the company and all shareholders. The company will comply with the “Shanghai Stock Exchange Stock Listing Rules” and other related matters
[BT Financial Report Instantaneous Analysis] ST Jiaong 2023 Quarterly Report: Balance Ratio Decreased, Net Profit Turned Negative, Net Cash Flow Declined
This financial report was announced at 18:12:48 ST on 2023-10-27 (stock code: 600530) is an enterprise mainly engaged in R&D, production and sales of health products, health product raw materials and terminal products. The company's main business includes R&D, production and sales of raw materials and terminal products for health products, and operation and management of geriatric medical care institutions. However, due to the impact of e-commerce and other issues, the sales scale of offline physical stores has shrunk sharply. In terms of assets and liabilities, ST's total assets for the third quarter of 2023 were 797 million yuan, compared to 8.85 at the end of the previous year
No Data